Q1: 2026-05-11 Earnings Summary EPS of -$0.14 beats by $0.06  |  Revenue of $8.32M (96.34% Y/Y) beats by $2.48M AbCellera Biologics Inc. ( ABCL ) Bank of America Global Healthcare Conference 2026 May 13, 2026 8:01 PM EDT Company Participants Carl L. Hansen - CEO, President & Chairperson Presentation Operator Bank of America's Annual Healthcare Conference in very toasty Las Vegas. I'm very happy to be joined here on stage with Carl Hansen with AbCellera. Thank you so much for joining. Carl L. Hansen CEO, President & Chairperson It's great to be here. Thanks for having me. Question-and-Answer Session Operator Wonderful. Maybe, for those who might be newer to the story, can you give us a brief overview of the company? And again, you've evolved from a successful discovery partner into a company now focused on advancing its own clinical assets. How did that evolution happen? Carl L. Hansen CEO, President & Chairperson Sure. So the company is now roughly 13 years old.…